Endovascular aneurysm repair (EVAR) has rapidly become the preferred management of abdominal aortic aneurysm (AAA). Sac regression status post-EVAR has been linked to clinical outcomes as well as the choice of EVAR device. The aim of this narrative review is to investigate the relationship between sac regression and clinical outcomes post-EVAR in AAA. Another aim is to compare sac regression achieved with the main EVAR devices. We carried out a comprehensive literature search on multiple electronic databases. Sac regression was usually defined as a decrease in the sac diameter (>10 mm) over follow-up. This revealed that individuals who had sac regression post-EVAR had significantly lower mortality, and higher event-free survival rates. Further, lower rates of endoleak and reintervention were observed in patients with regressing aneurysm sacs. Sac regression patients also had significantly lower odds of rupture compared to counterparts with stable or expanded sacs. The choice of EVAR device was also shown to impact regression, with the Fenestrated Anaconda showing favorable results. Sac regression post-EVAR in AAA is an important prognostic factor as it translates to improved mortality and morbidity. Therefore, this relationship must be seriously taken into consideration during follow-up.
Study Design: A retrospective analysis of oncologist-provided prognoses vs actual survival outcomes of patients referred with Metastatic spinal cord compression (MSCC) to a supra-regional multidisciplinary team (MDT). Objectives: Prognostic scoring systems, such as the revised Tokuhashi, are commonly used to help guide the treatment of MSCC. However, scoring systems do not accommodate for the improved outcomes of contemporary cancer therapy. Oncologist-provided prognoses play an important role in real world rapid decision making. There is a paucity of evidence assessing the accuracy of the oncologist-provided prognosis. We conducted a retrospective study to evaluate this. Methods: Data was captured between January 2015 and December 2018. Patients were split into 2 groups: Group 1 (prognosis estimated 6 months). Median overall survival (mOS) and hazard ratio for death (HR) was assessed. Receiver operating characteristic (ROC) analysis was performed to assess the accuracy of the oncologist’s prognosis. Results: 829 patients were included. mOS in Group 1 was 5.8 months (95% CI 4.2-7.4 m), and in Group 2 mOS was not reached. Log rank test gave a Chi 2 of 131 ( P < .001). Cox regression analysis revealed a HR of .30 ( P < .001). Area under the ROC curve was 78%. Conclusions: Oncologist-provided prognosis is accurate in this cohort of unselected, consecutive MSCC patients. It reduced reliance on scoring systems that can become outdated. Given the rapid progress in cancer treatment, the oncologist’s prognostic prediction is integral in efficient and effective MSCC management to help rapidly determine surgical candidacy.
1 April 2026 in Journal of Experimental Orthopaedics
Purpose: Gastrocnemius flap coverage is a widely used technique for soft‐tissue reconstruction in complex revision total knee arthroplasty (rTKA) for periprosthetic joint infection (PJI). However, clinical outcomes following one‐stage and two‐stage revision strategies in this context are poorly defined. The purpose of this meta‐analysis was to synthesize, critically appraise, systematically review and compare reinfection rates and complication profiles between one‐ and two‐stage septic rTKA for PJI using a gastrocnemius flap for reconstruction. Methods: A systematic review and meta‐analysis based on the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines was conducted. MEDLINE, Embase, Cochrane Library and Web of Science were searched from inception to 6 April 2025 for studies on patients undergoing rTKA for PJI with soft tissue reconstruction using a gastrocnemius flap. Outcomes of interest included reinfection rates, any complications and flap‐related complications. A pooled meta‐analysis at group level was performed to compare interventions. Results: There were 11 studies reporting on 271 rTKAs involving gastrocnemius flap reconstruction for PJI that met inclusion criteria. Of these, 56 were one‐stage rTKAs, while 215 were two‐stage rTKAs. PJI eradication rate was 66.1% in the one‐stage group versus 54.4% in the two‐stage group. There were no statistically significant differences between groups for reinfection (odds ratio [OR]: 0.61; 95% confidence interval [CI]: 0.33–1.13; p = 0.12), any complications (OR: 1.59; 95% CI: 0.71–3.54; p = 0.26) or flap‐related complications (OR: 1.03; 95% CI: 0.43–2.47; p = 0.94). Conclusion: It was found that one‐stage and two‐stage rTKA using a gastrocnemius flap showed comparable rates of reinfection, any complication and flap‐related complication with the data available for this meta‐analysis. Findings suggest that one‐stage revision may be a viable treatment option for suitable patients. However, higher‐quality studies are warranted to identify potential true differences within this high‐risk group. Level of Evidence: Level IV.
Amelia is a rare congenital malformation characterized by the complete absence of one or more limbs. We report the case of a 17-year-old boy with bilateral upper limb amelia and progressive thoracic scoliosis. He was fully independent in daily living, relying on his lower limbs for all activities. Radiographs demonstrated an 86° thoracic curve (T6–T12), skeletal maturity, and limited flexibility. Theoretical fusion to L3 or L4 risked major functional decline. He underwent selective thoracic fusion (T3–L1), sparing four lumbar discs. At 2-year follow-up, Cobb angle improved to 34°, SRS-22 score rose from 2.8 to 3.55, and independence was preserved. This case highlights the need to balance deformity correction with functional preservation in scoliosis management for patients with amelia.
11 December 2025 in Journal of Orthopaedic Reports